drugset
drugset / Trial / NCT05289440

Esketamine Administration on Recovery Quality After Radical Mastectomy

NCT05289440 ↗

Completed 105 enrolled Anqing Municipal Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Some studies have reported that intravenous esketamine reduce postoperative pain intensity. The investigators investigated whether esketamine could improve the the quality of recovery after modified radical mastectomy.

Timeline

Start
2022-03-15
Primary completion
2022-09-15
Completion
2022-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 2 ug/kg Intravenous
Subject Esketamine Other / unclassified 4 ug/kg Intravenous

Indications

No indication recorded.